Attachment of BoVine Capillary Endothelial Cells to Surfaces
J. Am. Chem. Soc., Vol. 120, No. 26, 1998 6551
(s, 9 H), 1.38 (s, 9 H), 1.54 (m, 2 H), 1.63 (m, 2 H), 1.75 (t, J ) 6.78
Hz, 2 H), 1.85 (m, 2 H), 2.05 (s, 3 H), 2.50 (s, 3 H), 2.51 (s, 3 H), 2.57
(t, J ) 6.72 Hz 2 H), 2.65 (dd, J ) 3.36, 17.00 Hz, 1 H), 2.78 (dd, J
) 4.20, 17.00 Hz, 1 H), 3.18 (bs, 2 H), 3.81-4.01 (m, 4 H), 4.50 (m,
1 H), 4.63 (m, 1 H), 5.03 (s, 2 H), 6.10-6.40 (m, 4 H), 7.25 (m, 5 H),
7.43 (m, 1 H), 7.77 (m, 1 H). HRMS (FAB) calcd for C44H65N7O12-
SNa (M + Na) 938.4310, found 938.4310.
3,6,9,12,15,18,21-Heptaoxadotriacont-31-enoic Acid, 1,1-Di-
methylethyl Ester (6). To a solution of alcohol 520,21 (1.04 g, 2.4
mmol) in dry DMF (5 mL) cooled to 0 °C was added NaH (144 mg of
60% suspension in oil, 3.6 mmol). The mixture was stirred at 0 °C
for 10 min, tert-butylbromoacetate (532 µL, 3.6 mmol) was added in
one portion, and the mixture was allowed to warm to room temperature.
After the mixture was stirred for 6 h additional tert-butylbromoacetate
(532 µL, 3.6 mmol) was added, and the stirring was continued at 40
°C for 10 h. After the mixture cooled to room temperature, EtOAc
(50 mL) was added, organic phase was washed with H2O and brine,
dried (MgSO4), and concentrated in vacuo. Column chromatography
(3% MeOH in CH2Cl2) afforded product 6 (0.81 g, 62%). 1H NMR
(400 MHz, CDCl3): δ 1.25 (bs, 10 H), 1.29-1.41 (m, 2 H), 1.45 (s, 9
H), 1.55 (m, 2 H), 2.01 (m, 2 H), 3.42 (t, J ) 6.80 Hz, 2H), 3.56 (m,
2 H), 3.60-3.73 (m, 22 H), 4.00 (s, 2 H), 4.89 (m, 2 H), 5.73-5.84
(m, 1 H). MS (FAB) calcd for C29H56O9Na (M + Na) 571, found
571.
L-Aspartic Acid, N-[(1-oxo-3,6,9,12,15,18,21-heptaoxatriacont-31-
en-1-yl)glycyl-N5-[[[(3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-ben-
zopyran-6-yl)sulfonyl]amino]iminomethyl]-L-ornithylglycyl-, Bis-
(1,1-dimethylethyl) Ester (8). To a solution of 6 (376 mg, 0.69 mmol)
in CH2Cl2 (5 mL), was added TFA (5 mL) and the mixture was stirred
for 3 h. After concentration in vacuo and column chromatography (10%
MeOH in CH2Cl2) heptaoxadotriacont-31-enoic acid 7 (290 mg, 0.59
mmol, 86%) was obtained. Z-Protected tetrapeptide 4 (507 mg, 0.65
mmol) was hydrogenated in EtOH (10 mL) over 10% Pd/C (0.1 g).
After filtration and concentration in vacuo the crude amine was
obtained. The amine and carboxylic acid 7 were combined, the flask
was purged with N2, dry DMF (3 mL) was added, and the stirred
solution was cooled to 0 °C. DPPA (150 µL, 4.38 mmol) was added,
followed by a solution of DIPEA (120 µL, 4.38 mmol) in DMF (1
mL), and the stirring was continued at 0 °C for 10 h. The mixture
was diluted with EtOAc (10 mL) and washed successively with H2O,
5% aqueous NaHCO3, and brine. The organic phase was dried
(MgSO4), and the solvent was removed in vacuo to give a residue which
was chromatographed (5% MeOH in CH2Cl2 f 10% MeOH in CH2Cl2)
to give product 8 (355 mg, 48%). 1H NMR (500 MHz, CDCl3): δ
1.25 (s, 10 H), 1.28 (s, 6 H), 1.30-1.36 (m, 2 H), 1.39 (s, 9 H), 1.40
(s, 9 H), 1.48-1.63 (m, 4 H), 1.68-1.75 (m, 1 H), 1.78 (t, J ) 6.80
Hz, 2 H), 1.89-1.95 (m, 1 H), 2.01 (q, J ) 6.85 Hz, 2 H), 2.07 (s, 3
H), 2.53 (s, 3 H), 2.55 (s, 3 H), 2.60 (t, J ) 6.70 Hz, 2 H), 2.67 (dd,
J ) 4.75, 16.94 Hz, 1 H), 2.79 (dd, J ) 5.01, 16.99 Hz, 1 H), 3.22 (m,
2 H), 3.40 (t, J ) 6.85 Hz, 2 H), 3.52-3.55 (m, 2 H), 3.58-3.64 (m,
22 H), 3.66-3.71 (m, 2 H), 3.88 (dd, J ) 5.68, 16.62 Hz, 1 H), 3.95
(dd, J ) 5.64, 14.47 Hz, 1 H), 3.98-4.05 (m, 2 H), 4.01 (s, 2 H), 4.46
(q, J ) 7.61 Hz, 1 H), 4.63 (dt, J ) 4.86, 8.04 Hz, 1 H), 4.88-5.00
(m, 2 H), 5.73-5.83 (m, 1 H), 6.36 (bs, 2 H), 7.11 (d, J ) 8.06 Hz, 1
H), 7.43 (bs, 1 H), 7.63 (bt, J ) 5.29 Hz, 1 H), 7.90 (t, J ) 5.76 Hz,
1 H). MS (FAB) calcd for C61H105N7O18SNa (M + Na) 1278, found
1278.
L-Aspartic Acid, N-[(1,34-Dioxo-3,6,9,12,15,18,21-heptaoxa-33-
thiapentatriacont-1-yl)glycyl-N5-[[[(3,4-dihydro-2,2,5,7,8-pentamethyl-
2H-1-benzopyran-6-yl)sulfonyl]amino]iminomethyl]-L-ornithyl-
glycyl-, Bis(1,1-dimethylethyl) Ester (9). A mixture of 8 (650 mg,
0.52 mmol), thioacetic acid (742 µL, 10.4 mmol), and AIBN (20 mg)
in THF (10 mL) was irradiated by UV. After 2 h additional AIBN
(20 mg) was added, and irradiation was continued for 3 h. The mixture
was concentrated in vacuo and chromatographed (5% MeOH in CH2Cl2
f 10% MeOH in CH2Cl2) to give thioacetate 9 (641 mg, 93%). 1H
NMR (500 MHz, CDCl3): δ 1.26 (bs, 12 H), 1.28 (s, 6 H), 1.28-1.33
(m, 2 H), 1.39 (s, 9 H), 1.40 (s, 9 H), 1.47-1.64 (m, 6 H), 1.68-1.75
(m, 1 H), 1.78 (t, J ) 6.80 Hz, 2 H), 1.88-1.96 (m, 1 H), 2.07 (s, 3
H), 2.28 (s, 3 H), 2.53 (s, 3 H), 2.54 (s, 3 H), 2.60 (t, J ) 6.68 Hz, 2
H), 2.68 (dd, J ) 4.80, 16.94 Hz, 1 H), 2.78 (dd, J ) 5.10, 16.96 Hz,
1 H), 2.82 (t, J ) 7.36, 2 H), 3.23 (m, 2 H), 3.40 (t, J ) 6.85 Hz, 2 H),
3.52-3.55 (m, 2 H), 3.58-3.64 (m, 22 H), 3.66-3.71 (m, 2 H), 3.87
(dd, J ) 5.70, 16.64 Hz, 1 H), 3.95 (dd, J ) 5.68, 14.48 Hz, 1 H),
3.98-4.05 (m, 2 H), 4.01 (s, 2 H), 4.45 (bq, J ) 7.52 Hz, 1 H), 4.63
(dt, J ) 4.90, 8.18 Hz, 1 H), 6.36 (bs, 2 H), 7.14 (d, J ) 8.07 Hz, 1
H), 7.52 (bs, 1 H), 7.71 (bs, 1 H), 7.94 (t, J ) 5.78 Hz, 1 H). MS
(FAB) calcd for C63H109N7O19S2Na (M + Na) 1354, found 1354.
L-Aspartic Acid, N-[(32-Mercapto-1-oxo-3,6,9,12,15,18,21-hep-
taoxatriacont-1-yl)glycyl-L-arginylglcyl- (1). A mixture of CF3COOH/
PhSMe/HS(CH2)2SH/H2O 37:1:1:1 (v/v) was used for cleavage of the
protective groups in 9. A solution of 9 (320 mg, 0.25 mmol) in CH2Cl2
(2 mL) was cooled 0 °C, and the cleavage mixture (10 mL) was added.
The obtained solution was stirred at 0 °C for 1 h, allowed to warm to
room temperature, and stirred for 2 h at room temperature. The mixture
was concentrated in vacuo, CH2Cl2 (10 mL) was added, and the mixture
was concentrated in vacuo again. The residue was dissolved in a
minimum amount of CH2Cl2, cold Et2O (50 mL) was added dropwise
into the flask with vigorous stirring, and the obtained precipitate was
filtered and dried in vacuo to afford AcS(CH2)11(OCH2CH2)6OCH2C-
(O)NHGRGDOH (195 mg, 0.20 mmol, 80%) as a white solid. MS
(FAB) calcd for C41H75N7O16SNa (M + Na) 976, found 976. The
obtained thioacetate was dissolved in absolute MeOH (10 mL), and
the solution was cooled 0 °C. NaOMe (1.54 mL of 0.39 M in MeOH,
0.60 mmol) was added, and the mixture was stirred at 0 °C for 3 h.
The mixture was neutralized with Dowex exchange resin (H-form),
filtered, and concentrated in vacuo. Repeated precipitation (3 times)
from CH2Cl2 with cold Et2O afforded pure 1 (63 mg, 34%). 1H NMR
(500 MHz, CD3OD): δ 1.27-1.46 (m, 12 H), 1.52-1.61 (m, 4 H),
1.63-1.71 (m, 2 H), 1.72-1.81 (m, 2 H), 1.92-2.00 (m, 2 H), 2.48 (t,
J ) 7.15 Hz, 2 H), 2.82 (t, J ) 5.41 Hz, 2 H), 3.20 (t, J ) 6.76 Hz,
2 H), 3.46 (t, J ) 6.62 Hz, 2 H), 3.57 (m, 2 H), 3.61-3.66 (m, 18 H),
3.68 (m, 2 H), 3.71 (m, 2 H), 3.84-4.02 (m, 4 H), 4.06 (s, 2 H), 4.40
(t, J ) 7.32 Hz, 1 H), 4.63 (t, J ) 5.50 Hz, 1 H); 13C NMR (125 MHz,
CDCl3): δ 24.97, 25.94, 27.20, 29.41, 30.22, 30.57, 30.65, 30.72, 35.22,
37.62, 42.02, 43.13, 43.39, 50.77, 54.33, 71.14, 71.19, 71.33, 71.43,
71.47, 71.52, 72.08, 72.37, 158.63, 171.06, 171.58, 173.74, 174.17,
174.92, 175.02. HRMS (FAB) calcd for C39H73N7O15SNa (M + Na)
934.4783, found 934.4805.
Preparation of SAMs. Substrates were prepared as previously
described,20,21 beginning with evaporation of titanium (1 nm) and gold
onto glass slides (38 nm of Au for SPR experiments; and 12 nm of Au
for cell culture).22 The slides were immersed in ethanolic solutions
containing mixtures of HSC11(EG)6OGRGD and HSC11(EG)3OH (2 mM
total thiol) in ethanol for 4 h. Ellipsometric measurements of mixed
SAMs of HSC11(EG)6OGRGD and HSC11(EG)3OH resulted in thick-
nesses ranging from 22.8 to 33.7 Å; these values are in good agreement
with those expected for a well-packed SAM containing trans-extended
alkanethiolates.21 In reporting the composition of the system in terms
of the parameter, øRGD, we assume the relative mole fractions of
(EG)6OGRGD and (EG)3OH groups on the surface and in solution to
be the same (eq 1). This assumption may be incorrect in detail, but
the relative trends will certainly be very similar.23
[EG6OGRGD]
øGRGD
)
(1)
[EG6OGRGD] + [EG3OH]
Fibronectin (FN) coated substrates, used as a positive control for
adhesion assays, were prepared by immersing metallized substrates in
hexadecanethiol (2 mM) in ethanol for 4 h; then, coated substrates were
placed in a solution of fibronectin in PBS (Collaborative Biomedical,
50 µg/mL) for 1 h. Another control substrate using a 20 amino acid
fragment containing RGD (Telios) coated on glass (RGD-glass) was
prepared by immersing glass coverslips in a solution of the peptide
(50 µg/mL) in sodium bicarbonate (100 mM, pH 9.4) overnight to
generate maximal coating density.
(22) SPR spectroscopy requires a reflective gold surface (38 nm of Au).
In contrast, a transparent surface (12 nm of Au) is required for the study of
cells.
(23) Prime and Whitesides (refs 17 and 18) found that the thickness of
mixed SAMs of (EG)n alkanethiolates increases almost linearly with
composition.